Giulia Buchmann

scientist in cardiovascular research @ vascular research center | Frankfurt

[BioNTech SE @BioNTech_Group]

BNT211 update at @myESMO: we shared positive follow-up data from our first-in-human Ph. 1/2 trial of our novel CAR-T cell therapy candidate. The data demonstrates encouraging signs of clinical anti-tumor activity & manageable safety & tolerability profile. https://t.co/9u5MeUTne0

[Institute for Cardiovascular Physiology @BrandesLab]

We're back again with another #poster at #RNA22! This time, it's Frederike's turn to share her research on how a #lncRNA acts to secure the #endothelial cell phenotype (Session 3 - Poster 409). Come and say hello!

[Institute for Cardiovascular Physiology @BrandesLab]

@CardioPhys_FFM put the pedal to the metal yesterday at #ecokartfrankfurt. Congratulations to those who reached the podium: @JamesAOo7 (🥇), @tim_warwick (🥈) and Tom Teichmann (🥉) 🍾. Well done to everyone who took part - it was great fun! 👏